References
- Carter JH, Flegel WA. Red cell transfusions in the genomics era. Semin Hematol 2019;56:236–40.
- Karafin MS, Howard J. Genotyping and the future of transfusion in sickle cell disease. Hematol Oncol Clin N Am 36:1271–84. doi:10.1016/j.hoc.2022.07.012.
- Westhoff CM. Blood group genotyping. Blood 2019;133: 1814–20.
- Svensson AM, Delaney M. 2015. Considerations of red blood cell molecular testing in transfusion medicine. Expert Rev Mol Diagn 2015;15:1455–64.
- Guelsin GAS, Rodrigues C, Visentainer JEL, et al. Molecular matching for RH and K reduces red blood cell alloimmunisation in patients with myelodysplastic syndrome. Blood Transfus 2015;13:53–8.
- Jadoon SA, Salamat N, Khan SA, Yazdani MS, Khatak N, Naeem MA. Genotyping for Dombrock blood group alleles in Northern Pakistani blood donors. Immunohematology 2021;37:113–17.
- Keller MA. The role of red cell genotyping in transfusion medicine. Immunohematology 2015;31:49–52.
- Sullivan JKC, Gleadall N, Lane WJ. Blood group genotyping. Clin Lab Med 2022;42:645–68. doi:10.1016/j.cll.2022.09.016.
- Horn T, Hamilton J, Kosanke J, et al. Assessment of common red blood cell pretreatments to yield an accurate serologic antigen phenotype compared with genotype-predicted phenotype. Immunohematology 2019;33:147–51. doi: 10.21307/immunohematology-2019-020.
- Guz K, Orzińska A, Michalewska B, Pelc-Kłopotowska M, Brojer E, Łętowska M. Molecular biology methods for blood cell antigen genotyping in reference laboratories. J Transf Med 2019;12:199–205.
- Pelc-Kłopotowska M, Guz K, Orzińska A, et al. Antibodies against high frequency antigen in Polish patients between 2000 and 2017. Vox Sang 2018;113(suppl 1):227.
- Sandler SG, Chen LN, Flegel WA. Serological weak D phenotypes: a review and guidance for interpreting the RhD blood type using the RHD genotype. Br J Haematol 2017;179:10–9. doi: 10.1111/bjh.14757.
- Anani WQ, Marchan MG, Bensing KM, et al. Practical approaches and costs for provisioning safe transfusions during anti-CD38 therapy. Transfusion 2017;57:1470–9. doi:10.1111/trf.14021.
- Chou ST, Flanagan JM, Vege S, et al. Whole-exome sequencing for RH genotyping and alloimmunization risk in children with sickle cell anemia. Blood Adv 2017;1:1414–22.
- Hui YMT, Gurung K, Layton DM, Ibidapo M, Grimsley S, Regan F. Sickle cell disease patients in two London trusts: genotyping including RH variants. Transfus Med 2022;32:210–20. doi:10.1111/tme.12838.
- Van Buren NL, Gorlin JB, Corby SM, et al. How do I incorporate red cell genotyping to improve chronic transfusion therapy? Transfusion 2020;60:16–25. doi:10.1111/trf.15599.
- Fasano RM, Chou ST. Red blood cell antigen genotyping for sickle cell disease, thalassemia, and other transfusion complications. Transfus Med Rev 2016;30:197–201.
- Chou ST, Alsawas M, Fasano RM, et al. American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support. Blood Adv 2020;4:327–55. doi.org/10.1182/bloodadvances.2019001143.
- Chou ST, Westhoff CM. Application of genomics for transfusion therapy in sickle cell anemia. Blood Cells Mol Dis 2017;67: 148–54.
- Clausen FB, Hellberg A, Bein G, et al. Recommendation for validation and quality assurance of non-invasive prenatal testing for foetal blood groups and implications for IVD risk classification according to EU regulations. Vox Sang 2022;117:157–65. doi:10.1111/vox.13172.
- Clausen FB. Antenatal RHD screening to guide antenatal anti-D immunoprophylaxis in non-immunized D− pregnant women. Immunohematology 2024;40:15–27. DOI: 10.2478/immunohematology-2024-004.
- Sandler SG, Flegel WA, Westhoff CM, et al. College of American Pathologists Transfusion Medicine Resource Committee Work Group. It’s time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group. Transfusion. 2015 Mar;55(3):680–9. doi: 10.1111/trf.12941.
- Gleadall NS, Veldhuisen B, Gollub J, et al. Development and validation of a universal blood donor genotyping platform: a multinational prospective study. Blood Adv 2020;4:3495–506. doi:10.1182/bloodadvances.2020001894.
- Kielsen K, Scharff BFSS, Hansen AT, et al. Genotyping of blood donors for timely procurement of rare antigen-negative blood: a case story of acute HTR and anti-coa. J Blood Disord Transfus 2023;14:553. doi:10.4172/2155-9864.23.14.553.
- Shih AW, Yan MTS, Elahie AL, et al. Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk-stratify patients for alloimmunisation risk. Transfus Med 2020;30:263–74.
- Menegati SFP, Santos TD, Macedo MD, Castilho L. Discrepancies between red cell phenotyping and genotyping in daily immunohematology laboratory practice. Transfus Apher Sci. 2020;59:102585. doi:10.1016/j.transci.2019.06.020.
- Latini FRM, Castilho LM. An overview of the use of SNaPshot for genotyping blood group antigens. Immunohematology 2015;31:53–7.
- McBean RS, Hyland CA, Flower RL. Blood group genotyping: the power and limitations of the Hemo ID panel and MassARRAY platform. Immunohematology 2015;31:75–80.
- Veldhuisen B, van der Schoot CE, de Haas M. Multiplex ligation-dependent probe amplification (MLPA) assay for blood group genotyping, copy number quantification, and analysis of RH variants. Immunohematology 2015;31:58–61.
- Denomme GA, Schanen MJ. Mass-scale donor red cell genotyping using real-time array technology. Immunohematology 2015;31:69–74.
- Fürst D, Tsamadou C, Neuchel C, Schrezenmeier H, Mytilineos J, Weinstock C. Next-generation sequencing technologies in blood group typing. Transfus Med Hemother 2020;47:4–13.
- Giollo M, Minervini G, Scalzotto M, et al. BOOGIE: predicting blood groups from high throughput sequencing data. PLoS ONE 2015;10:e0124579.
- Lane WJ, Westhoff CM, Gleadall NS, et al. Automated typing of red blood cell and platelet antigens: a whole-genome sequencing study. Lancet Haematol 2018;5:e241–51.
- Lane WJ, Westhoff CM, Uy JM, et al. Comprehensive red blood cell and platelet antigen prediction from whole genome sequencing: proof of principle. Transfusion 2016;56:743–54.
- Lane WJ, Vege S, Mah HH, et al. Automated typing of red blood cell and platelet antigens from whole exome sequences. Transfusion 2019;59: 3253–63. doi:10.1111/trf.15473.
- Lane WJ, Aguad M, Smeland-Wagman R, et al. A whole genome approach for discovering the genetic basis of blood group antigens: independent confirmation for P1 and Xga. Transfusion. 2019;59:908–15.
- Chang T-C, Haupfear KM, Yu J, et al. A novel algorithm comprehensively characterizes human RH genes using wholegenome sequencing data. Blood Adv 2020;4:4347–57.
- Montemayor-Garcia C, Karagianni P, Stiles DA, et al. Genomic coordinates and continental distribution of 120 blood group variants reported by the 1000 Genomes Project. Transfusion 2018;58:2693–704.
- Schoeman EM, Roulis EV, Liew Y-W, et al. Targeted exome sequencing defines novel and rare variants in complex blood group serology cases for a red blood cell reference laboratory setting. Transfusion 2018;58:284–93.
- Schoeman EM, Lopez GH, McGowan EC, et al. Evaluation of targeted exome sequencing for 28 protein-based blood group systems, including the homologous gene systems, for blood group genotyping: sequencing for blood group genotyping. Transfusion 2017;57:1078–88.
- Moller M, Joud M, Storry JR, et al. Erythrogene: a database for in-depth analysis of the extensive variation in 36 blood group systems in the 1000 Genomes Project. Blood Adv 2016;1: 240–9.
- Moller M, Hellberg A, Olsson ML. Thorough analysis of unorthodox ABO deletions called by the 1000 Genomes project. Vox Sang 2018;113:185–97.
- Wagner FF, Flegel WA. The Rhesus Site. Transfus Med Hemother. 2014 Oct;41(5):357–63. doi: 10.1159/000366176.
- Shin KH, Lee HJ, Park KH, Hye BM, Chang CL, Kim HH. Extended red blood cell genotyping to investigate immunohematology problems. Ann Lab Med 2018;38: 387–88.